Determination of transforming growth factor activity in effusions from cancer patients

Axel‐R ‐R Hanauske, Carlos L. Arteaga, Gary M. Clark, Joy Buchok, Martha Marshall, Parul Hazarika, Robert L. Pardue, Daniel D. Von Hoff

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Transforming growth factors (TGF) are polypeptides that stimulate anchorage‐independent growth of various nontransformed cells in vitro. Transforming growth factors have been found in tumor extracts and in the urine of cancer patients. The specific questions of our study were whether TGF activity can be detected in malignant effusions, how different assays for TGF correlate with each other, and how assays for TGF correlate with soft agar tumor colony formation as measured by the human tumor cloning assay (HTCA). The TGF activity was measured by a normal rat kidney transformation assay (NRKA), a 125I‐EGF radioreceptor assay (RRA), and a radioimmunoassay (RIA) for TGF‐α. Cells from effusions were cytologically examined and plated in the HTCA. A total of 104 effusions from cancer patients and 17 effusions from non‐cancer patients was tested. Transforming growth factor activity was detected in some specimens. Only the TGF‐α RIA and the HTCA showed significant differences between cancer and noncancer patients. Immunoreactive TGF‐α was measurable in some cases by RIA even when cytologic testing failed to detect malignant cells. Spearman correlations between assays indicated that RIA results correlate significantly with all other assays. It is concluded that TGF‐α activity might be important for in vitro colony formation of human tumor cells.

Original languageEnglish (US)
Pages (from-to)1832-1837
Number of pages6
JournalCancer
Volume61
Issue number9
DOIs
StatePublished - Jan 1 1988

Fingerprint

Transforming Growth Factors
Neoplasms
Radioimmunoassay
Organism Cloning
Radioligand Assay
Agar
Urine
Kidney
Peptides

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Determination of transforming growth factor activity in effusions from cancer patients. / Hanauske, Axel‐R ‐R; Arteaga, Carlos L.; Clark, Gary M.; Buchok, Joy; Marshall, Martha; Hazarika, Parul; Pardue, Robert L.; Von Hoff, Daniel D.

In: Cancer, Vol. 61, No. 9, 01.01.1988, p. 1832-1837.

Research output: Contribution to journalArticle

Hanauske, ARR, Arteaga, CL, Clark, GM, Buchok, J, Marshall, M, Hazarika, P, Pardue, RL & Von Hoff, DD 1988, 'Determination of transforming growth factor activity in effusions from cancer patients', Cancer, vol. 61, no. 9, pp. 1832-1837. https://doi.org/10.1002/1097-0142(19880501)61:9<1832::AID-CNCR2820610919>3.0.CO;2-J
Hanauske, Axel‐R ‐R ; Arteaga, Carlos L. ; Clark, Gary M. ; Buchok, Joy ; Marshall, Martha ; Hazarika, Parul ; Pardue, Robert L. ; Von Hoff, Daniel D. / Determination of transforming growth factor activity in effusions from cancer patients. In: Cancer. 1988 ; Vol. 61, No. 9. pp. 1832-1837.
@article{09ff59d9be1a4ec69f2140da2e985010,
title = "Determination of transforming growth factor activity in effusions from cancer patients",
abstract = "Transforming growth factors (TGF) are polypeptides that stimulate anchorage‐independent growth of various nontransformed cells in vitro. Transforming growth factors have been found in tumor extracts and in the urine of cancer patients. The specific questions of our study were whether TGF activity can be detected in malignant effusions, how different assays for TGF correlate with each other, and how assays for TGF correlate with soft agar tumor colony formation as measured by the human tumor cloning assay (HTCA). The TGF activity was measured by a normal rat kidney transformation assay (NRKA), a 125I‐EGF radioreceptor assay (RRA), and a radioimmunoassay (RIA) for TGF‐α. Cells from effusions were cytologically examined and plated in the HTCA. A total of 104 effusions from cancer patients and 17 effusions from non‐cancer patients was tested. Transforming growth factor activity was detected in some specimens. Only the TGF‐α RIA and the HTCA showed significant differences between cancer and noncancer patients. Immunoreactive TGF‐α was measurable in some cases by RIA even when cytologic testing failed to detect malignant cells. Spearman correlations between assays indicated that RIA results correlate significantly with all other assays. It is concluded that TGF‐α activity might be important for in vitro colony formation of human tumor cells.",
author = "Hanauske, {Axel‐R ‐R} and Arteaga, {Carlos L.} and Clark, {Gary M.} and Joy Buchok and Martha Marshall and Parul Hazarika and Pardue, {Robert L.} and {Von Hoff}, {Daniel D.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1002/1097-0142(19880501)61:9<1832::AID-CNCR2820610919>3.0.CO;2-J",
language = "English (US)",
volume = "61",
pages = "1832--1837",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Determination of transforming growth factor activity in effusions from cancer patients

AU - Hanauske, Axel‐R ‐R

AU - Arteaga, Carlos L.

AU - Clark, Gary M.

AU - Buchok, Joy

AU - Marshall, Martha

AU - Hazarika, Parul

AU - Pardue, Robert L.

AU - Von Hoff, Daniel D.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Transforming growth factors (TGF) are polypeptides that stimulate anchorage‐independent growth of various nontransformed cells in vitro. Transforming growth factors have been found in tumor extracts and in the urine of cancer patients. The specific questions of our study were whether TGF activity can be detected in malignant effusions, how different assays for TGF correlate with each other, and how assays for TGF correlate with soft agar tumor colony formation as measured by the human tumor cloning assay (HTCA). The TGF activity was measured by a normal rat kidney transformation assay (NRKA), a 125I‐EGF radioreceptor assay (RRA), and a radioimmunoassay (RIA) for TGF‐α. Cells from effusions were cytologically examined and plated in the HTCA. A total of 104 effusions from cancer patients and 17 effusions from non‐cancer patients was tested. Transforming growth factor activity was detected in some specimens. Only the TGF‐α RIA and the HTCA showed significant differences between cancer and noncancer patients. Immunoreactive TGF‐α was measurable in some cases by RIA even when cytologic testing failed to detect malignant cells. Spearman correlations between assays indicated that RIA results correlate significantly with all other assays. It is concluded that TGF‐α activity might be important for in vitro colony formation of human tumor cells.

AB - Transforming growth factors (TGF) are polypeptides that stimulate anchorage‐independent growth of various nontransformed cells in vitro. Transforming growth factors have been found in tumor extracts and in the urine of cancer patients. The specific questions of our study were whether TGF activity can be detected in malignant effusions, how different assays for TGF correlate with each other, and how assays for TGF correlate with soft agar tumor colony formation as measured by the human tumor cloning assay (HTCA). The TGF activity was measured by a normal rat kidney transformation assay (NRKA), a 125I‐EGF radioreceptor assay (RRA), and a radioimmunoassay (RIA) for TGF‐α. Cells from effusions were cytologically examined and plated in the HTCA. A total of 104 effusions from cancer patients and 17 effusions from non‐cancer patients was tested. Transforming growth factor activity was detected in some specimens. Only the TGF‐α RIA and the HTCA showed significant differences between cancer and noncancer patients. Immunoreactive TGF‐α was measurable in some cases by RIA even when cytologic testing failed to detect malignant cells. Spearman correlations between assays indicated that RIA results correlate significantly with all other assays. It is concluded that TGF‐α activity might be important for in vitro colony formation of human tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=0023928853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023928853&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19880501)61:9<1832::AID-CNCR2820610919>3.0.CO;2-J

DO - 10.1002/1097-0142(19880501)61:9<1832::AID-CNCR2820610919>3.0.CO;2-J

M3 - Article

C2 - 3162700

AN - SCOPUS:0023928853

VL - 61

SP - 1832

EP - 1837

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 9

ER -